Building healthcare in China

Life Science

For many American companies, China is land of opportunity

Life Science

Portugal’s parliament legalizes cannabis-based medicines

Cannabis, Life Science

China National Drug Administration Approves Country’s First Immuno-Oncology Agent, Opdivo (nivolumab injection), for Previously Treated Non-Small Cell Lung Cancer (NSCLC)

Life Science

Blueprint Medicines Announces Updated Data from Ongoing Phase 1 EXPLORER Clinical Trial of Avapritinib in Patients with Advanced Systemic Mastocytosis Showing Profound and Durable Clinical Activity

Life Science

Aptose Acquires China Rights to Leukemia Candidate in $125 Million Agreement

Life Science

Venus Medtech Enters North American Market

Life Science

Australian Medical Device Firm Sirtex Accepts CHD’s $1.4B Acquisition Bid

Life Science

Pharnext Announces PXT3003 was Granted Priority Review by the China Food and Drug Administration

Life Science

Johnson & Johnson Innovation Announces Launch of Shanghai Lung Cancer Innovation QuickFire Challenge

Life Science

Yaoshibang Closes $65.7 Million C Round for Online Pharmacy

Life Science

Mevion Raises $150 Million from China Investors for Proton Therapy Machines

Life Science

Life Science & Technology Weekly 147 – Shanghai Kinetic Acquires US Device Maker Elliquence for $77 Million

Life Science, Technology

Meet New Featured Investment Opportunities on NAI500 – Takung Art, AXMIN Inc, Eastwood Bio-Medical

Life Science, Mining, Others, Precious Metals, Technology

Eisai Plans Invests $100M in Genetics Guided Dementia Discovery Facility in Cambridge, Mass.

Life Science